Skip to main content
Supplement ScienceSupplementScience

Types of GABA: Forms & Bioavailability

Evidence:Emerging
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
PharmaGABA (Naturally Fermented)ModerateStress and relaxation — produced by Lactobacillus hilgardii fermentation, most clinically studied form
Synthetic GABALow-ModerateBudget option — chemically identical but less studied than PharmaGABA in clinical trials
GABA Chewable / SublingualModerate-HighRapid onset — sublingual absorption may bypass some first-pass metabolism for faster effects

PharmaGABA (Naturally Fermented)

Bioavailability: Moderate. Best for: Stress and relaxation — produced by Lactobacillus hilgardii fermentation, most clinically studied form.

Synthetic GABA

Bioavailability: Low-Moderate. Best for: Budget option — chemically identical but less studied than PharmaGABA in clinical trials.

GABA Chewable / Sublingual

Bioavailability: Moderate-High. Best for: Rapid onset — sublingual absorption may bypass some first-pass metabolism for faster effects.

References

  1. RCTAbdou AM, Higashiguchi S, Horie K, Kim M, Hatta H, Yokogoshi H (2006). Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. BioFactors. DOI PubMed
  2. RCTNakamura H, Takishima T, Kometani T, Yokogoshi H (2009). Psychological stress-reducing effect of chocolate enriched with gamma-aminobutyric acid (GABA) in humans. International Journal of Food Sciences and Nutrition. DOI PubMed
  3. Meta-analysisGodfrey K, Douglass H, Erritzoe D, Muthukumaraswamy S, et al. (2025). The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysis.. Progress in neuro-psychopharmacology & biological psychiatry. DOI PubMed
  4. Meta-analysisPasanta D, He JL, Ford T, Oeltzschner G, et al. (2023). Functional MRS studies of GABA and glutamate/Glx - A systematic review and meta-analysis.. Neuroscience and biobehavioral reviews. DOI PubMed
  5. Meta-analysisSimmonite M, Steeby CJ, Taylor SF (2023). Medial Frontal Cortex GABA Concentrations in Psychosis Spectrum and Mood Disorders: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.. Biological psychiatry. DOI PubMed
  6. Kumar V, Vajawat B, Rao NP (2021). Frontal GABA in schizophrenia: A meta-analysis of 1H-MRS studies.. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. DOI PubMed
  7. Porges EC, Jensen G, Foster B, Edden RA, et al. (2021). The trajectory of cortical GABA across the lifespan, an individual participant data meta-analysis of edited MRS studies.. eLife. DOI PubMed
Show 2 more references
  1. Kantrowitz JT, Dong Z, Milak MS, Rashid R, et al. (2021). Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder.. Translational psychiatry. DOI PubMed
  2. Sydnor VJ, Roalf DR (2020). A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk.. Schizophrenia research. DOI PubMed